Stock Upgrades: Legend Biotech Corp Shows Rising Relative Strength
Legend Biotech Corp saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, with an upgrade from 77 to 84.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
This proprietary rating tracks technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price action over the trailing 52 weeks matches up against that of all other stocks.
Over 100 years of market history reveals that the stocks that go on to make the biggest gains often have an 80 or better RS Rating as they launch their biggest climbs.
Legend Biotech Corp is working on a consolidation with a 49.59 entry. See if it can break out in heavy trading.
Earnings growth fell last quarter from 0% to -57%. But revenue gains moved higher, from 18% to 74%.
Legend Biotech Corp holds the No. 149 rank among its peers in the Medical-Biomed/Biotech industry group. Maravai Lifesciences and Biontech Se Ads are also among the group's highest-rated stocks.